← FDA DRUG APPROVALS

FDA ANDA · ANDA091659

HEPARIN SODIUM

Sponsor: CASI PHARMS INC

APPLICATION
ANDA091659
TYPE
ANDA
ORIGINAL APPROVAL
2011-06-08
LATEST ACTION
2012-10-12
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

HEPARIN SODIUMDiscontinued
HEPARIN SODIUM 5,000 UNITS/ML · INJECTABLE · INJECTION

Approval history

2012-10-12Labeling · Supplement 1AP
2011-06-08Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →